The ZFTA gene helps control which other genes are active in developing brain cells. When it is rearranged and no longer works in the usual controlled way, it can help drive some ependymomas, a type of tumor that forms in the brain or spinal cord. In medicine, ZFTA is mainly known for these gene fusions, especially ZFTA-RELA, rather than for common inherited variants.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or regulate processes in the body. Some genes provide the directions for producing proteins, the parts of cells that do much of the work. Other genes mainly help control when certain processes happen, where they happen, and how active they are. Together, genes affect how the body develops and works, and they can also shape how you respond to food, stress, or medicines. For a deeper look at this topic, you can find more in the LearnHub.
Overview
ZFTAGene function
What if the gene works
The ZFTA gene helps control how other genes are switched on, especially during brain development. Its protein can bind DNA, which supports normal cell growth and cell identity.
Risk
What if the gene does not work
Certain DNA changes involving the ZFTA gene, especially fusions with RELA, are linked to supratentorial ependymoma, a brain tumor. Milder or more disruptive changes can affect gene activity differently, which may influence when it appears and its features.
Treatment
What does that mean for your treatment
No ZFTA-specific treatment or drug choice is currently established in clinical guidelines. Changes involving the ZFTA gene are used mainly to classify certain brain tumors, and ZFTA fusion proteins are being studied as possible drug targets.
Conditions associated with ZFTA
Gene function
What if the gene works
Healthy growth depends on cells turning the right instructions on at the right time. The ZFTA gene helps with that control, especially in developing brain tissue. Its protein works mainly in the nucleus, where cells manage their genetic instructions.
Cells use the ZFTA gene to help control which other genes are active and which stay quieter. This supports normal patterns of cell activity as tissues grow and organize.
Its protein has small regions that help it attach to DNA. That contact helps guide how cells read and use genetic instructions.
ZFTA is especially active in the developing brain, where careful timing of gene activity matters. This supports the ZFTA gene's role in brain development as cells mature and take on specialized jobs.
What is a variant?
Genetic variants are small differences in a gene’s DNA sequence. They are common and help explain normal human diversity, including differences in appearance, metabolism, and the way the body reacts to environmental influences. Many have no noticeable effect and are simply part of natural genetic variation. Sometimes, though, a variant changes how a gene works more substantially and can contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Most impactful changes in the ZFTA gene are structural variants that join it to another gene, most often RELA. These fusions create an abnormal hybrid protein that can switch on growth-related genes at the wrong time and change how cells behave. In plain terms, this is how ZFTA gene variants affect protein function at the cellular level. Different fusion partners, and the exact place where the DNA rejoins, can make these effects milder or stronger.
How variants are linked to conditions
Changes involving the ZFTA gene are most clearly linked to a brain tumor called supratentorial ependymoma, ZFTA fusion-positive. In practice, ZFTA gene variants linked to conditions most often refer to acquired gene fusions found in the tumor, usually in children but sometimes in adults. These changes help confirm the diagnosis in tumor testing. They are not usually used to describe an inherited family risk condition.
A variant is not necessarily a diagnosis
Genetic variants are a routine part of human biology, and they are common throughout the general population. Most have no direct impact on health and simply reflect natural human variation. For many genes, carrying a variant connected with a condition suggests a possible association rather than a clear diagnosis, especially when several genes and environmental factors contribute. In some situations, though, a single well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce risk related to ZFTA. Most ZFTA-related findings are changes that happen in tumor cells rather than inherited changes passed through families, so personal risk is not usually shaped by known lifestyle factors.
Inheritance of ZFTA variants
For families asking how variants of the ZFTA gene are inherited, there is not yet a broadly confirmed inherited pattern tied to a specific ZFTA related condition. Most of the best known ZFTA changes in medicine are found only in tumor cells, which means they arise during life rather than being passed from a parent to a child. The ZFTA gene is located on chromosome 11, which is an autosome, so each person inherits one copy from each parent.
What does my ZFTA result mean for my family?
There is not yet a broadly confirmed inherited pattern linking ZFTA to a specific family condition. If you have a ZFTA result and want to understand what it could mean for relatives, a genetics specialist can explain it in the context of your exact finding and health history.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for ZFTA variants is usually done on tumor tissue, because ZFTA changes are most often checked as part of a brain tumor workup rather than with routine inherited testing. Labs use methods such as DNA or RNA sequencing to look for ZFTA fusions or other changes and help confirm the tumor type.
When should I consider getting a genetic test?
There is not a broadly established reason for inherited testing of the ZFTA gene based on family history alone. If someone has a brain tumor, doctors may test the tumor itself for changes involving ZFTA to help identify the tumor type and guide care.
A genetic result is only one part of your health story
A genetic result can provide valuable insight, but what it reveals depends on the condition and the type of variant involved. Many factors, including lifestyle, environment, age, and medical history, affect how the body functions over time. For some conditions, especially those shaped by many genes, genetic information provides context rather than certainty and is most useful when viewed alongside other parts of care. In other situations, a genetic result can offer a clear answer. In areas like medication response, genetic results can also help put personal experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body responds to medicines. Some people break down a drug more slowly or more quickly than others, so the same dose can lead to different effects. This is a common reason why a treatment may work well for one person, work less well for another, or cause more side effects in someone else. These differences can influence both how helpful a medicine is and how sensitive a person may be to it.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in genes can shape a person’s response to medications. It focuses on connections between genes and drugs to better understand why the same treatment can work differently from one person to another. For many medicines, genes affect how strongly a drug works or how the body processes it. This information can help support treatment decisions that are more informed and more personalized. You can read more about this topic in the LearnHub.
Drugs influenced by the ZFTA gene
When should I seek medical advice?
There isn’t yet a broadly confirmed role for this gene in guiding how medicines are chosen or dosed. For general medication questions, side effects, or concerns about how treatment may affect you, it’s best to speak with your doctor or pharmacist.
History
The ZFTA gene entered medical research under its earlier name, C11orf95, during efforts to map genes on chromosome 11. Over time, scientists’ understanding of the gene’s function has changed. A major turning point came in the 2010s, when researchers found that rearrangements involving this gene, especially ZFTA-RELA fusions, were closely linked to a group of brain tumors called supratentorial ependymomas. That discovery helped reshape tumor classification and moved diagnosis beyond what could be seen under a microscope alone. As knowledge grew, C11orf95 was renamed ZFTA, reflecting its role in this area of cancer genetics and modern tumor profiling.